Preeclampsia pathogenesis: "triple a rating"-autoantibodies and antiangiogenic factors.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  HYPERTENSION

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.107.100735PMID 18259040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling

  2008cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia

  2007cited by this paper
• Dysregulation of the Circulating and Tissue-Based Renin–Angiotensin System in Preeclampsia

  2007cited by this paper
• Angiotensin II Induces Soluble fms-Like Tyrosine Kinase-1 Release via Calcineurin Signaling Pathway in Pregnancy

  2007cited by this paper
• Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia?

  2007cited by this paper
• Negative Regulation of Soluble Flt-1 and Soluble Endoglin Release by Heme Oxygenase-1

  2007cited by this paper
• Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

  2006cited by this paper
• Soluble endoglin contributes to the pathogenesis of preeclampsia

  2006cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• J Soc Gynecol Investig

  2005cited by this paper
• Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.

  2005cited by this paper
• Latest Advances in Understanding Preeclampsia

  2005cited by this paper
• Angiotensin II Type 1 Receptor Agonistic Antibodies Reflect Fundamental Alterations in the Uteroplacental Vasculature

  2005cited by this paper
• Role of the renin-angiotensin system in the pathogenesis of preeclampsia.

  2005cited by this paper
• Evidence for compromised aldosterone synthase enzyme activity in preeclampsia.

  2004cited by this paper
• Antibodies From Preeclamptic Patients Stimulate Increased Intracellular Ca2+ Mobilization Through Angiotensin Receptor Activation

  2004cited by this paper
• Maternal Autoantibodies From Preeclamptic Patients Active Angiotensin Receptors on Human Trophoblast Cells

  2003cited by this paper
• AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor.

  2000cited by this paper
• Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension

  2000cited by this paper
• Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

  1999cited by this paper

• Stimulation of Angiotensin II Receptor Subtype 2 Reduces Preeclampsia-like Symptoms in a Mouse Model of Preeclampsia

  2024cites this paper
• THE ROLE OF PREDICTOR PLACENTAL GROWTH FACTOR, SOLUBLE ENDOGLIN, SOLUBLE-FMS-LIKE-TYROSINE KINASE-1 AND PULSATIL UTERINA ARTERIAL INDEX TO PREDICT THE EARLY ONSET OF PREECLAMPSIA

  2020cites this paper
• Increased incidence of preeclampsia in mothers of advanced age conceiving by oocyte donation

  2018cites this paper
• Endothelial Dysfunction as a Consequence of Endothelial Glycocalyx Damage: A Role in the Pathogenesis of Preeclampsia

  2018cites this paper
• The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy

  2017cites this paper
• Comparison of serum soluble edoglin (sEng) level in eary onset preeclampsia, late onset preeclampsia and normal pregnant woman

  2017cites this paper
• Biomarker PlGF/sFlt-1 sebagai Pendeteksi Dini Preeklampsia

  2017cites this paper
• Analysis of transcriptional activities of angiogenic biomarkers during intrauterine complications leading to preterm birth.

  2017cites this paper
• Hypertension and renal toxicity during angiogenesis inhibition : Salt dependency and treatment options

  2016cites this paper
• Predictors of Impaired Postpartum Renal Function in Women after Preeclampsia: Results of a Prospective Single Center Study

  2016cites this paper
• Injeksi Serum Mengandung TNF-α Tinggi Menurunkan Konsentrasi VEGF dan Ekspresi Nephrin Glomerulus Mencit Bunting Injection of Serum Containing High TNF-α Lowers VEGF Concentration and Nephrin Expression of Pregnant Mice

  2016cites this paper
• Oxidative stress in preeclampsia and the role of free fetal hemoglobin

  2015cites this paper
• FAKTOR ANGIOGENIK SOLUBLE FMS-LIKE TYROSINE KINASE-1 DAN VASCULAR ENDOTHELIAL GROWTH FACTOR PADA IBU HAMIL 8 – 20 MINGGU DENGAN RISIKO PREEKLAMPSIA

  2015cites this paper
• Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies

  2015cites this paper
• Pulse wave velocity in normotensive and hypertensive pregnant women at University Teaching Hospital (UTH), Lusaka, Zambia

  2015cites this paper
• The role of microRNAs on angiogenesis and vascular pressure in preeclampsia: The evidence from systematic review

  2015cites this paper
• Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II

  2015cites this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)

  2014cites this paper
• Role of biomarkers in early detection of preeclampsia.

  2014cites this paper
• Placental angiogenin inhibitor (ribonuclease inhibitor), a novel gene in pre-eclampsia.

  2013cites this paper
• Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1

  2013cites this paper
• Angiogenesis and Preeclampsia

  2012cites this paper
• Preeclampsia: Molecular Mechanisms, Predisposition, and Treatment

  2012cites this paper
• Preeclampsia, Hypoxia, Thrombosis, and Inflammation

  2011cites this paper
• Endothelial progenitor cells: Their potential role in pregnancy and preeclampsia.

  2011cites this paper
• A longitudinal study of plasma levels of soluble fms‐like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF‐A) in normal pregnancy

  2011cites this paper
• A guide towards pre-pregnancy management of defective implantation and placentation.

  2011cites this paper
• Case records of the Massachusetts General Hospital. Case 28-2010. A 32-year-old woman, 3 weeks post partum, with substernal chest pain.

  2010cites this paper
• Hypertension in pregnancy: classification, diagnosis and treatment

  2010cites this paper
• Prenatal stretching exercise and autonomic responses: preliminary data and a model for reducing preeclampsia.

  2010cites this paper
• Biomarkers in Obstetric Medicine

  2010cites this paper
• Hypertension in Pregnancy: List of abbreviations

  2010cites this paper
• Vascular endothelial growth factor inhibitors and hypertension: a central role for the kidney and endothelial factors?

  2009cites this paper
• Etiopathology of preeclampsia

  2009cites this paper
• Is preeclampsia an autoimmune disease?

  2009cites this paper
• Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers.

  2009cites this paper
• Chapter 6 – Angiogenesis and Preeclampsia

  2009cites this paper
• Preeclampsia: the role of angiogenic factors in its pathogenesis.

  2009cites this paper
• Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor.

  2009cites this paper
• Optimal laboratory panel for predicting preeclampsia

  2009cites this paper
• How should women with pre-eclampsia be followed up? New insights from mechanistic studies

  2008cites this paper
• Are we getting closer to a Nobel Prize for unraveling preeclampsia?

  2008cites this paper